| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.98e-07 | 11 | 101 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.90e-07 | 151 | 101 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA4 ATAD5 DNAH2 MSH4 BPTF SLFN13 NAE1 EIF4A2 SMARCA4 POLQ ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 2.55e-06 | 614 | 101 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA4 ATAD5 DNAH2 SLFN13 EIF4A2 SMARCA4 POLQ ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.44e-05 | 441 | 101 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 3.21e-05 | 36 | 101 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 3.21e-05 | 36 | 101 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E PKD1L1 ITPR1 SLC9C1 PKD1 KCNK2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.23e-04 | 465 | 101 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.31e-04 | 109 | 101 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.75e-04 | 62 | 101 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1E ABCA4 PKD1L1 SLC1A5 ITPR1 SLC7A9 SLC7A2 SLC9C1 SIDT2 PKD1 KCNK2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SLC2A11 | 2.75e-04 | 1180 | 101 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.68e-04 | 127 | 101 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1E ABCA4 PKD1L1 SLC1A5 ITPR1 SLC7A9 SLC7A2 SLC9C1 SIDT2 PKD1 KCNK2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 SLC2A11 | 7.25e-04 | 1289 | 101 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E PKD1L1 ITPR1 SLC9C1 PKD1 KCNK2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.28e-03 | 627 | 101 | 10 | GO:0022890 |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 1.04e-05 | 29 | 98 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1E TMEM161B CASR ITGA1 BCR SLC1A5 SEMA3A SLC7A2 ERAP2 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.31e-05 | 733 | 98 | 13 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 5.01e-05 | 84 | 98 | 5 | GO:0051480 | |
| GeneOntologyCellularComponent | perichromatin fibrils | 6.02e-06 | 8 | 101 | 3 | GO:0005726 | |
| GeneOntologyCellularComponent | cilium | TMEM67 ABCA4 TTLL9 PKD1L1 PCDH11Y DNAH2 AGBL4 EYS SLC9C1 PKD1 CEP41 CC2D2A TMEM231 ATP2B2 ATP2B4 | 2.63e-05 | 898 | 101 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | MKS complex | 3.83e-05 | 14 | 101 | 3 | GO:0036038 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.13e-04 | 98 | 101 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 TMEM67 ABCA4 STON1 WDR83 WASHC3 C2CD5 ITPR1 TMEM106B USP8 VAC14 USO1 RABEP1 HGS PKD1 ATP2B1 VPS13B | 1.65e-04 | 1307 | 101 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MON2 TMEM67 ABCA4 STON1 WDR83 WASHC3 C2CD5 ITPR1 TMEM106B USP8 VAC14 USO1 RABEP1 HGS PKD1 ATP2B1 VPS13B | 1.94e-04 | 1325 | 101 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | cell projection membrane | TMEM67 PKD1L1 C2CD5 SLC7A9 SLC9C1 PKD1 TMEM231 ATP2B1 ATP2B2 | 2.43e-04 | 431 | 101 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | early endosome membrane | 5.77e-04 | 212 | 101 | 6 | GO:0031901 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.21e-03 | 164 | 101 | 5 | GO:0098982 | |
| HumanPheno | Oculomotor apraxia | 1.97e-05 | 117 | 38 | 7 | HP:0000657 | |
| HumanPheno | Generalized neonatal hypotonia | 2.11e-05 | 23 | 38 | 4 | HP:0008935 | |
| HumanPheno | Abnormal cerebral subcortex morphology | CACNA1E TMEM67 EOGT DIS3L2 CASR COG8 ITPR1 TMEM106B BPTF USP8 VAC14 KMT2D SALL1 NAE1 EIF4A2 CEP41 SMARCA4 CC2D2A NUP188 TMEM231 VPS13B | 2.59e-05 | 1207 | 38 | 21 | HP:0010993 |
| HumanPheno | Abnormal cerebral white matter morphology | CACNA1E TMEM67 EOGT DIS3L2 COG8 ITPR1 TMEM106B BPTF USP8 VAC14 KMT2D SALL1 NAE1 EIF4A2 CEP41 SMARCA4 CC2D2A NUP188 TMEM231 VPS13B | 2.99e-05 | 1114 | 38 | 20 | HP:0002500 |
| HumanPheno | Retinal coloboma | 3.48e-05 | 86 | 38 | 6 | HP:0000480 | |
| HumanPheno | Lobar holoprosencephaly | 3.50e-05 | 26 | 38 | 4 | HP:0006870 | |
| HumanPheno | Abnormal third toe morphology | 4.43e-05 | 10 | 38 | 3 | HP:0010320 | |
| HumanPheno | Abnormal pancreas morphology | 1.19e-04 | 107 | 38 | 6 | HP:0012090 | |
| HumanPheno | Pancreatic cysts | 1.31e-04 | 36 | 38 | 4 | HP:0001737 | |
| HumanPheno | Apraxia | 1.59e-04 | 218 | 38 | 8 | HP:0002186 | |
| HumanPheno | Abnormal corpus callosum morphology | CACNA1E TMEM67 DIS3L2 COG8 ITPR1 TMEM106B VAC14 KMT2D SALL1 NAE1 EIF4A2 CEP41 SMARCA4 CC2D2A NUP188 TMEM231 VPS13B | 1.60e-04 | 937 | 38 | 17 | HP:0001273 |
| HumanPheno | Aplasia/Hypoplasia of the tongue | 1.80e-04 | 39 | 38 | 4 | HP:0010295 | |
| HumanPheno | Small eyes | 1.83e-04 | 285 | 38 | 9 | HP:0001143 | |
| HumanPheno | Microphthalmia | 1.83e-04 | 285 | 38 | 9 | HP:0000568 | |
| HumanPheno | Molar tooth sign on MRI | 1.99e-04 | 40 | 38 | 4 | HP:0002419 | |
| HumanPheno | Cystic liver disease | 2.19e-04 | 41 | 38 | 4 | HP:0006706 | |
| HumanPheno | Thin corpus callosum | CACNA1E TMEM67 DIS3L2 COG8 ITPR1 TMEM106B VAC14 KMT2D SALL1 NAE1 EIF4A2 CEP41 SMARCA4 CC2D2A NUP188 TMEM231 | 2.34e-04 | 868 | 38 | 16 | HP:0033725 |
| HumanPheno | Prominent eyelashes | 2.42e-04 | 17 | 38 | 3 | HP:0011231 | |
| HumanPheno | Aplasia/Hypoplasia affecting the eye | TMEM67 EOGT ABCA4 DIS3L2 ARV1 CASR ITPR1 SEMA3A VAC14 EYS KMT2D SALL1 EIF4A2 CEP41 CC2D2A NUP188 TMEM231 ATP2B2 VPS13B | 2.74e-04 | 1183 | 38 | 19 | HP:0008056 |
| HumanPheno | Holoprosencephaly | 2.82e-04 | 80 | 38 | 5 | HP:0001360 | |
| HumanPheno | Abnormality of the hypothalamus-pituitary axis | TMEM67 MSH4 SEMA3A BPTF USP8 KMT2D PKD1 CEP41 CC2D2A TMEM231 VPS13B | 2.95e-04 | 449 | 38 | 11 | HP:0000864 |
| HumanPheno | Aplasia/Hypoplasia of the 3rd toe | 3.22e-04 | 4 | 38 | 2 | HP:0010331 | |
| HumanPheno | Abnormal toe morphology | TMEM67 EOGT MSH4 BCR COG8 ITPR1 BPTF VAC14 KMT2D SALL1 CEP41 SMARCA4 CC2D2A TMEM231 ATP2B1 VPS13B | 3.28e-04 | 893 | 38 | 16 | HP:0001780 |
| HumanPheno | Iris coloboma | 3.38e-04 | 183 | 38 | 7 | HP:0000612 | |
| HumanPheno | Episodic tachypnea | 3.43e-04 | 46 | 38 | 4 | HP:0002876 | |
| HumanPheno | Congenital hepatic fibrosis | 3.43e-04 | 46 | 38 | 4 | HP:0002612 | |
| HumanPheno | Abnormality of globe size | 4.27e-04 | 319 | 38 | 9 | HP:0100887 | |
| HumanPheno | Sclerocornea | 4.39e-04 | 49 | 38 | 4 | HP:0000647 | |
| HumanPheno | True hermaphroditism | 4.64e-04 | 21 | 38 | 3 | HP:0010459 | |
| HumanPheno | Abnormal morphology of the great vessels | EOGT DIS3L2 PKD1L1 BCR ITPR1 BPTF VAC14 KMT2D SALL1 NAE1 EIF4A2 PKD1 SMARCA4 ATP2B1 | 5.06e-04 | 736 | 38 | 14 | HP:0030962 |
| HumanPheno | Aplasia/Hypoplasia of the retina | TMEM67 ABCA4 ARV1 ITPR1 SEMA3A EYS CEP41 CC2D2A TMEM231 ATP2B2 VPS13B | 5.09e-04 | 478 | 38 | 11 | HP:0008061 |
| HumanPheno | Aplasia of the distal phalanges of the toes | 5.34e-04 | 5 | 38 | 2 | HP:0010645 | |
| HumanPheno | Pancreatic fibrosis | 5.35e-04 | 22 | 38 | 3 | HP:0100732 | |
| HumanPheno | Choroid coloboma | 5.52e-04 | 52 | 38 | 4 | HP:0000611 | |
| HumanPheno | Chorioretinal coloboma | 5.52e-04 | 52 | 38 | 4 | HP:0000567 | |
| HumanPheno | Tachypnea | 5.68e-04 | 93 | 38 | 5 | HP:0002789 | |
| HumanPheno | Abnormal fifth toe morphology | 5.96e-04 | 94 | 38 | 5 | HP:0010322 | |
| HumanPheno | Cerebellar malformation | TMEM67 COG8 ITPR1 KMT2D SALL1 EIF4A2 CEP41 SMARCA4 CC2D2A TMEM231 ATP2B3 | 5.98e-04 | 487 | 38 | 11 | HP:0002438 |
| HumanPheno | Highly arched eyebrow | 6.92e-04 | 206 | 38 | 7 | HP:0002553 | |
| HumanPheno | Urinary tract atresia | 6.96e-04 | 24 | 38 | 3 | HP:0000809 | |
| HumanPheno | Urethral atresia | 6.96e-04 | 24 | 38 | 3 | HP:0000068 | |
| HumanPheno | Multicystic kidney dysplasia | 7.22e-04 | 98 | 38 | 5 | HP:0000003 | |
| HumanPheno | Aplasia/Hypoplasia of the middle phalanges of the toes | 7.98e-04 | 6 | 38 | 2 | HP:0010194 | |
| Domain | ATP_Ca_trans_C | 8.06e-10 | 4 | 101 | 4 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 8.06e-10 | 4 | 101 | 4 | PF12424 | |
| Domain | P-type_ATPase_IIB | 8.06e-10 | 4 | 101 | 4 | IPR006408 | |
| Domain | ATPase_P-typ_TM_dom | 1.39e-06 | 16 | 101 | 4 | IPR023298 | |
| Domain | - | 1.39e-06 | 16 | 101 | 4 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.82e-06 | 17 | 101 | 4 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.82e-06 | 17 | 101 | 4 | PF00689 | |
| Domain | Cation_ATPase_N | 2.33e-06 | 18 | 101 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 2.33e-06 | 18 | 101 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.93e-06 | 19 | 101 | 4 | IPR004014 | |
| Domain | ATP2B1/4 | 2.90e-05 | 2 | 101 | 2 | IPR030319 | |
| Domain | ATPase_P-typ_cyto_domN | 3.71e-05 | 35 | 101 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 4.15e-05 | 36 | 101 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 4.15e-05 | 36 | 101 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 4.15e-05 | 36 | 101 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 4.64e-05 | 37 | 101 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 4.64e-05 | 37 | 101 | 4 | PF00122 | |
| Domain | REJ | 1.73e-04 | 4 | 101 | 2 | PS51111 | |
| Domain | REJ_dom | 1.73e-04 | 4 | 101 | 2 | IPR014010 | |
| Domain | Bromodomain_CS | 3.65e-04 | 26 | 101 | 3 | IPR018359 | |
| Domain | PKD/REJ-like | 4.28e-04 | 6 | 101 | 2 | IPR002859 | |
| Domain | REJ | 4.28e-04 | 6 | 101 | 2 | PF02010 | |
| Domain | PKD | 5.97e-04 | 7 | 101 | 2 | PF00801 | |
| Domain | C2 | 7.27e-04 | 131 | 101 | 5 | PF00168 | |
| Domain | VWA_3 | 7.94e-04 | 8 | 101 | 2 | PF13768 | |
| Domain | Nuc_translocat | 7.94e-04 | 8 | 101 | 2 | IPR001067 | |
| Domain | HAD-like_dom | 8.87e-04 | 79 | 101 | 4 | IPR023214 | |
| Domain | C2 | 8.90e-04 | 137 | 101 | 5 | SM00239 | |
| Domain | GPS | 9.63e-04 | 36 | 101 | 3 | PS50221 | |
| Domain | PKD/Chitinase_dom | 1.02e-03 | 9 | 101 | 2 | IPR022409 | |
| Domain | PKD | 1.02e-03 | 9 | 101 | 2 | SM00089 | |
| Domain | VWFA | 1.02e-03 | 82 | 101 | 4 | PS50234 | |
| Domain | GPS | 1.04e-03 | 37 | 101 | 3 | IPR000203 | |
| Domain | BROMODOMAIN_1 | 1.04e-03 | 37 | 101 | 3 | PS00633 | |
| Domain | C2 | 1.04e-03 | 142 | 101 | 5 | PS50004 | |
| Domain | VWA | 1.12e-03 | 84 | 101 | 4 | SM00327 | |
| Domain | Bromodomain | 1.13e-03 | 38 | 101 | 3 | PF00439 | |
| Domain | - | 1.26e-03 | 148 | 101 | 5 | 2.60.40.150 | |
| Domain | Hydrolase_3 | 1.27e-03 | 10 | 101 | 2 | PF08282 | |
| Domain | BROMODOMAIN_2 | 1.41e-03 | 41 | 101 | 3 | PS50014 | |
| Domain | Bromodomain | 1.51e-03 | 42 | 101 | 3 | IPR001487 | |
| Domain | BROMO | 1.51e-03 | 42 | 101 | 3 | SM00297 | |
| Domain | - | 1.51e-03 | 42 | 101 | 3 | 1.20.920.10 | |
| Domain | PKD | 1.54e-03 | 11 | 101 | 2 | PS50093 | |
| Domain | PKD_dom | 1.54e-03 | 11 | 101 | 2 | IPR000601 | |
| Domain | PKD_channel | 1.54e-03 | 11 | 101 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 1.54e-03 | 11 | 101 | 2 | IPR013122 | |
| Domain | - | 1.54e-03 | 11 | 101 | 2 | 2.60.40.670 | |
| Domain | C2_dom | 1.97e-03 | 164 | 101 | 5 | IPR000008 | |
| Domain | VWF_A | 2.05e-03 | 99 | 101 | 4 | IPR002035 | |
| Domain | AA_permease_2 | 2.17e-03 | 13 | 101 | 2 | PF13520 | |
| Domain | AA/rel_permease1 | 2.17e-03 | 13 | 101 | 2 | IPR002293 | |
| Domain | ARM-type_fold | 2.44e-03 | 339 | 101 | 7 | IPR016024 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.62e-03 | 106 | 101 | 4 | IPR000152 | |
| Domain | VWA | 3.46e-03 | 56 | 101 | 3 | PF00092 | |
| Domain | LH2 | 4.19e-03 | 18 | 101 | 2 | SM00308 | |
| Domain | EGF_CA | 4.35e-03 | 122 | 101 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.60e-03 | 124 | 101 | 4 | IPR001881 | |
| Domain | EGF | 4.87e-03 | 126 | 101 | 4 | PF00008 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.93e-07 | 27 | 76 | 5 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 3.56e-07 | 28 | 76 | 5 | M924 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.74e-07 | 12 | 76 | 4 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 7.49e-07 | 14 | 76 | 4 | MM15052 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.32e-06 | 36 | 76 | 5 | M39831 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.26e-06 | 76 | 76 | 6 | MM15051 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 6.71e-06 | 86 | 76 | 6 | M916 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.03e-05 | 54 | 76 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.03e-05 | 54 | 76 | 5 | MM15202 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.90e-05 | 103 | 76 | 6 | MM15196 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.94e-05 | 165 | 76 | 7 | MM15026 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.06e-05 | 130 | 76 | 6 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.09e-04 | 203 | 76 | 7 | M5485 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.39e-04 | 147 | 76 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.61e-04 | 151 | 76 | 6 | M39329 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.16e-04 | 55 | 76 | 4 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.48e-04 | 57 | 76 | 4 | MM15643 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.92e-04 | 178 | 76 | 6 | M2890 | |
| Pathway | WP_CILIOPATHIES | 4.67e-04 | 184 | 76 | 6 | M39880 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 7.31e-04 | 33 | 76 | 3 | M188 | |
| Pathway | WP_JOUBERT_SYNDROME | 7.46e-04 | 76 | 76 | 4 | M39835 | |
| Pathway | WP_BARDETBIEDL_SYNDROME | 1.29e-03 | 88 | 76 | 4 | M45557 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 6.97e-11 | 4 | 102 | 4 | 12209837 | |
| Pubmed | 6.97e-11 | 4 | 102 | 4 | 12784250 | ||
| Pubmed | 6.97e-11 | 4 | 102 | 4 | 15101689 | ||
| Pubmed | 6.97e-11 | 4 | 102 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 6.97e-11 | 4 | 102 | 4 | 8245032 | |
| Pubmed | 6.97e-11 | 4 | 102 | 4 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 6.97e-11 | 4 | 102 | 4 | 8634322 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 6.97e-11 | 4 | 102 | 4 | 7989379 | |
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 6.97e-11 | 4 | 102 | 4 | 11152753 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 6.97e-11 | 4 | 102 | 4 | 36130203 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 6.97e-11 | 4 | 102 | 4 | 10434059 | |
| Pubmed | 3.48e-10 | 5 | 102 | 4 | 17938178 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.04e-09 | 6 | 102 | 4 | 12767889 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.40e-09 | 38 | 102 | 6 | 30786075 | |
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 10951186 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM67 EOGT ARV1 TMEM161B ITGA1 ITPR1 SEMA3A TXNL1 TMEM106B VAC14 FAT1 NAE1 OSMR TMEM231 ATP2B1 TANGO6 DCAF12 | 7.61e-08 | 1201 | 102 | 17 | 35696571 |
| Pubmed | Congenital Hepatic Fibrosis Overview ─ RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.58e-07 | 52 | 102 | 5 | 20301743 | |
| Pubmed | 4.87e-07 | 6 | 102 | 3 | 12763866 | ||
| Pubmed | 1.57e-06 | 29 | 102 | 4 | 15071553 | ||
| Pubmed | 3.02e-06 | 34 | 102 | 4 | 20301500 | ||
| Pubmed | ATAD5 PFDN5 ARFIP1 TRIM24 SLC1A5 C2CD5 ITPR1 TXNL1 ERAP2 NAE1 HGS TMEM231 ATP2B1 NBR1 ATP2B4 VPS13B | 6.78e-06 | 1487 | 102 | 16 | 33957083 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18657858 | ||
| Pubmed | The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity. | 8.52e-06 | 2 | 102 | 2 | 16412504 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16956963 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8187550 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 1674727 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 1313367 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 1531651 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15178683 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22252018 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16291816 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25690014 | ||
| Pubmed | Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets. | 8.52e-06 | 2 | 102 | 2 | 10748016 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17823248 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26116539 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31065107 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23266958 | ||
| Pubmed | Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. | 8.52e-06 | 2 | 102 | 2 | 16216224 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.19e-05 | 100 | 102 | 5 | 25807483 | |
| Pubmed | ABCA4 TTLL9 ATAD5 DNAH2 TRIM24 USP8 KMT2D SALL1 ATP2B1 ATP2B3 | 1.89e-05 | 638 | 102 | 10 | 31182584 | |
| Pubmed | Ciliary Hedgehog signaling regulates cell survival to build the facial midline. | 2.29e-05 | 19 | 102 | 3 | 34672258 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 34948386 | ||
| Pubmed | A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation. | 2.55e-05 | 3 | 102 | 2 | 28827723 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 34315337 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 31123786 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33098669 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19854836 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17689535 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20211863 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22183401 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 1827443 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19574260 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11786550 | ||
| Pubmed | CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. | 2.55e-05 | 3 | 102 | 2 | 15133509 | |
| Pubmed | 3.34e-05 | 418 | 102 | 8 | 34709266 | ||
| Pubmed | 3.49e-05 | 686 | 102 | 10 | 29987050 | ||
| Pubmed | 3.65e-05 | 209 | 102 | 6 | 36779422 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18029012 | ||
| Pubmed | PSD95beta regulates plasma membrane Ca2+ pump localization at the photoreceptor synapse. | 5.09e-05 | 4 | 102 | 2 | 19233278 | |
| Pubmed | The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin. | 5.09e-05 | 4 | 102 | 2 | 10318760 | |
| Pubmed | Gfap and Osmr regulation by BRG1 and STAT3 via interchromosomal gene clustering in astrocytes. | 5.09e-05 | 4 | 102 | 2 | 29142070 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 16735509 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 36674959 | ||
| Pubmed | 5.50e-05 | 225 | 102 | 6 | 25277244 | ||
| Pubmed | MON2 SAAL1 ATAD5 ME1 SLC1A5 ITPR1 KMT2D HGS PLCL2 ATP2B1 NBR1 ATP2B4 | 5.95e-05 | 1049 | 102 | 12 | 27880917 | |
| Pubmed | 6.62e-05 | 143 | 102 | 5 | 20424473 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 7.61e-05 | 28 | 102 | 3 | 27002738 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 11018023 | ||
| Pubmed | A deubiquitinating enzyme UBPY regulates the level of protein ubiquitination on endosomes. | 8.47e-05 | 5 | 102 | 2 | 16771824 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 22832196 | ||
| Pubmed | Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism. | 8.47e-05 | 5 | 102 | 2 | 25405894 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 20736164 | ||
| Pubmed | Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice. | 8.47e-05 | 5 | 102 | 2 | 18258656 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 23153581 | ||
| Pubmed | Physical and genetic maps of the deafwaddler region on distal mouse Chr 6. | 8.47e-05 | 5 | 102 | 2 | 9615221 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 24828152 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.04e-04 | 31 | 102 | 3 | 18195088 | |
| Pubmed | 1.07e-04 | 83 | 102 | 4 | 28794006 | ||
| Pubmed | 1.12e-04 | 84 | 102 | 4 | 15123239 | ||
| Pubmed | 1.23e-04 | 504 | 102 | 8 | 34432599 | ||
| Pubmed | 1.23e-04 | 163 | 102 | 5 | 16512683 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 8530061 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 11274188 | ||
| Pubmed | Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. | 1.27e-04 | 6 | 102 | 2 | 15347669 | |
| Pubmed | Recruitment of UBPY and ESCRT exchange drive HD-PTP-dependent sorting of EGFR to the MVB. | 1.27e-04 | 6 | 102 | 2 | 23477725 | |
| Pubmed | ITGA1 BCR SLC1A5 COG8 ITPR1 USO1 CEP41 SMARCA4 NUP188 ATP2B1 NBR1 ATP2B4 | 1.63e-04 | 1168 | 102 | 12 | 19946888 | |
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 14701734 | ||
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 26595381 | ||
| Pubmed | POST, partner of stromal interaction molecule 1 (STIM1), targets STIM1 to multiple transporters. | 1.77e-04 | 7 | 102 | 2 | 22084111 | |
| Pubmed | 1.77e-04 | 7 | 102 | 2 | 9576906 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.77e-04 | 398 | 102 | 7 | 35016035 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.87e-04 | 536 | 102 | 8 | 15840001 | |
| Pubmed | 1.91e-04 | 538 | 102 | 8 | 10512203 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TRIM24 BPTF ARNT KMT2D SALL1 USO1 SMARCA4 ATP2B1 ATP2B3 NBR1 | 2.16e-04 | 857 | 102 | 10 | 25609649 |
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 2.36e-04 | 8 | 102 | 2 | 21447625 | |
| Pubmed | Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. | 2.36e-04 | 8 | 102 | 2 | 9697703 | |
| Pubmed | ATAD5 WDR83 TRIM24 SLC1A5 BPTF FAT1 ARNT KMT2D SALL1 HGS SMARCA4 HAL TANGO6 | 2.82e-04 | 1429 | 102 | 13 | 35140242 | |
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 35296311 | ||
| Pubmed | 3.03e-04 | 9 | 102 | 2 | 9704006 | ||
| Pubmed | Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover. | 3.03e-04 | 9 | 102 | 2 | 19427866 | |
| Interaction | TPST2 interactions | 1.75e-07 | 124 | 99 | 8 | int:TPST2 | |
| Interaction | C17orf78 interactions | 2.63e-07 | 12 | 99 | 4 | int:C17orf78 | |
| Interaction | HSD17B6 interactions | 7.17e-07 | 15 | 99 | 4 | int:HSD17B6 | |
| Interaction | GJD3 interactions | MON2 ARFIP1 SLC1A5 ITPR1 TXNL1 USP8 SLC7A2 USO1 HGS ATP2B1 NBR1 VPS13B | 2.32e-06 | 454 | 99 | 12 | int:GJD3 |
| Interaction | B3GAT1 interactions | MON2 ARFIP1 SLC1A5 ITPR1 TXNL1 SLC7A2 USO1 HGS ATP2B1 NBR1 VPS13B | 2.46e-06 | 377 | 99 | 11 | int:B3GAT1 |
| Interaction | AVPR2 interactions | 2.48e-06 | 123 | 99 | 7 | int:AVPR2 | |
| Interaction | CYP2B6 interactions | 6.33e-06 | 8 | 99 | 3 | int:CYP2B6 | |
| Interaction | LILRB4 interactions | 1.02e-05 | 28 | 99 | 4 | int:LILRB4 | |
| Interaction | RAB9A interactions | MON2 ARFIP1 SLC1A5 TMEM106B VAC14 USO1 RABEP1 HGS TMEM231 ATP2B1 ATP2B4 VPS13B | 3.50e-05 | 595 | 99 | 12 | int:RAB9A |
| Interaction | DEFB135 interactions | 5.31e-05 | 42 | 99 | 4 | int:DEFB135 | |
| Interaction | FPR2 interactions | 6.14e-05 | 138 | 99 | 6 | int:FPR2 | |
| Interaction | C19orf38 interactions | 6.57e-05 | 86 | 99 | 5 | int:C19orf38 | |
| Interaction | OPALIN interactions | 7.75e-05 | 209 | 99 | 7 | int:OPALIN | |
| Interaction | RGS9BP interactions | 8.89e-05 | 18 | 99 | 3 | int:RGS9BP | |
| Interaction | GOLIM4 interactions | 9.06e-05 | 92 | 99 | 5 | int:GOLIM4 | |
| Interaction | C5AR1 interactions | 1.13e-04 | 154 | 99 | 6 | int:C5AR1 | |
| Interaction | BET1 interactions | 1.18e-04 | 385 | 99 | 9 | int:BET1 | |
| Interaction | ENTPD7 interactions | 1.33e-04 | 53 | 99 | 4 | int:ENTPD7 | |
| Interaction | KCMF1 interactions | 1.34e-04 | 159 | 99 | 6 | int:KCMF1 | |
| Interaction | IL2RA interactions | 1.44e-04 | 54 | 99 | 4 | int:IL2RA | |
| Interaction | HSF4 interactions | 1.65e-04 | 56 | 99 | 4 | int:HSF4 | |
| GeneFamily | ATPases Ca2+ transporting | 1.66e-08 | 9 | 63 | 4 | 1209 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | STON1 ATAD5 GRK5 CST8 ME1 ITIH5 SEMA3A SLC7A2 FAT1 ARNT HMCN1 LACC1 SLFN13 ALDH3B2 ATP2B4 | 2.51e-06 | 773 | 98 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 5.40e-06 | 147 | 98 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 2.69e-05 | 76 | 98 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 5.97e-05 | 146 | 98 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 7.74e-05 | 153 | 98 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | GRK5 CST8 TRIM24 ME1 SEMA3A SLC7A2 HMCN1 CEP41 ADGRF5 HSF2 ATP2B1 ATP2B3 ATP2B4 | 1.09e-04 | 827 | 98 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | GRK5 CST8 TRIM24 ME1 ITIH5 ITPR1 SEMA3A SLC7A2 ARNT HMCN1 ATP2B3 ATP2B4 | 1.53e-04 | 740 | 98 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_100 | 1.58e-04 | 23 | 98 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_100 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.31e-08 | 189 | 102 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-07 | 182 | 102 | 7 | 3b4dbf61ca0fe50efe05449815630e301cb76630 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-07 | 182 | 102 | 7 | ab5761bf9af439231cd0f487b6467e372672a517 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.36e-07 | 185 | 102 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-07 | 191 | 102 | 7 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-07 | 191 | 102 | 7 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 3.14e-07 | 193 | 102 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.14e-07 | 193 | 102 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.25e-07 | 194 | 102 | 7 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.25e-07 | 194 | 102 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.25e-07 | 194 | 102 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.36e-07 | 195 | 102 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.36e-07 | 195 | 102 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.40e-06 | 167 | 102 | 6 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 175 | 102 | 6 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-06 | 175 | 102 | 6 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-06 | 184 | 102 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-06 | 184 | 102 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.33e-06 | 185 | 102 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.33e-06 | 185 | 102 | 6 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 186 | 102 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.46e-06 | 186 | 102 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 188 | 102 | 6 | 4ddb11a90bf3baa7237bde304db44dfcc56aed52 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 188 | 102 | 6 | e47e66906922d5c69b1aafe28face0787d3fc563 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 4.89e-06 | 189 | 102 | 6 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 190 | 102 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 5.04e-06 | 190 | 102 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.19e-06 | 191 | 102 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.19e-06 | 191 | 102 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 5.51e-06 | 193 | 102 | 6 | aa3acc7571405169efb656d214f3a8cbf988362e | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.02e-06 | 196 | 102 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 197 | 102 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 6.20e-06 | 197 | 102 | 6 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.38e-06 | 198 | 102 | 6 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.38e-06 | 198 | 102 | 6 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.38e-06 | 198 | 102 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.38e-06 | 198 | 102 | 6 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.38e-06 | 198 | 102 | 6 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.57e-06 | 199 | 102 | 6 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.57e-06 | 199 | 102 | 6 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.57e-06 | 199 | 102 | 6 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.57e-06 | 199 | 102 | 6 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.57e-06 | 199 | 102 | 6 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 6.76e-06 | 200 | 102 | 6 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.02e-05 | 174 | 102 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.30e-05 | 176 | 102 | 5 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.45e-05 | 177 | 102 | 5 | 6e330aa3c87fd640526b746a9deb3b2250d2518c | |
| ToppCell | P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.45e-05 | 177 | 102 | 5 | e96a7e4544710aaab8bd2800ecff9667880a8bf4 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 179 | 102 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-05 | 179 | 102 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-05 | 181 | 102 | 5 | b0fff0defba9aea6fba36e378b05a59986e2573a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.06e-05 | 181 | 102 | 5 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-05 | 181 | 102 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-05 | 181 | 102 | 5 | cc77ac0e223e012767222e45c5dcadc246d1aa7c | |
| ToppCell | facs-Lung-18m-Endothelial-lymphatic_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-05 | 181 | 102 | 5 | ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-05 | 181 | 102 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 182 | 102 | 5 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.22e-05 | 182 | 102 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.22e-05 | 182 | 102 | 5 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 182 | 102 | 5 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.22e-05 | 182 | 102 | 5 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.38e-05 | 183 | 102 | 5 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-05 | 183 | 102 | 5 | f142b320023eef00b48d4820c46214c9794d37e7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 184 | 102 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 185 | 102 | 5 | 6a85399cfdb9b89683c874e7f046957f9a601dc2 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 6.72e-05 | 185 | 102 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 185 | 102 | 5 | 64791056cdbb739136dbef08f4b16e2b5427faad | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.89e-05 | 186 | 102 | 5 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-05 | 186 | 102 | 5 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.89e-05 | 186 | 102 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.07e-05 | 187 | 102 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.07e-05 | 187 | 102 | 5 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.07e-05 | 187 | 102 | 5 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 188 | 102 | 5 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 7.25e-05 | 188 | 102 | 5 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.25e-05 | 188 | 102 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 189 | 102 | 5 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.43e-05 | 189 | 102 | 5 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.43e-05 | 189 | 102 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 189 | 102 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 190 | 102 | 5 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.62e-05 | 190 | 102 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 190 | 102 | 5 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.62e-05 | 190 | 102 | 5 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.62e-05 | 190 | 102 | 5 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.62e-05 | 190 | 102 | 5 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 191 | 102 | 5 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 191 | 102 | 5 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.81e-05 | 191 | 102 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-05 | 192 | 102 | 5 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 8.00e-05 | 192 | 102 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.20e-05 | 193 | 102 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.20e-05 | 193 | 102 | 5 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.20e-05 | 193 | 102 | 5 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.20e-05 | 193 | 102 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 8.40e-05 | 194 | 102 | 5 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.40e-05 | 194 | 102 | 5 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| Drug | C12E8 | 3.21e-08 | 42 | 102 | 6 | CID000123921 | |
| Drug | 1sqc | 7.81e-08 | 10 | 102 | 4 | CID000444279 | |
| Drug | cyhexatin | 8.09e-08 | 25 | 102 | 5 | CID005364545 | |
| Drug | 2,5-dimethylquinone | 1.22e-07 | 11 | 102 | 4 | CID000008718 | |
| Drug | octaethylene glycol | 1.78e-07 | 29 | 102 | 5 | CID000078798 | |
| Drug | lanthanum | 1.80e-07 | 136 | 102 | 8 | CID000023926 | |
| Drug | 1vyq | 1.83e-07 | 12 | 102 | 4 | CID004369390 | |
| Drug | Ro 46861 | 1.83e-07 | 12 | 102 | 4 | CID000003128 | |
| Drug | 8-hydroxycoumarin | 2.63e-07 | 13 | 102 | 4 | CID000122783 | |
| Drug | p-hydroxyhippuric acid | 3.67e-07 | 14 | 102 | 4 | CID000151012 | |
| Drug | mag-fura-2 | 6.36e-07 | 37 | 102 | 5 | CID000123839 | |
| Drug | gramicidin s | 6.36e-07 | 37 | 102 | 5 | CID000073357 | |
| Drug | AC1L88YH | 8.64e-07 | 17 | 102 | 4 | CID000374551 | |
| Drug | agelasine B | 1.94e-06 | 46 | 102 | 5 | CID006439899 | |
| Drug | XeC compound | 2.14e-06 | 84 | 102 | 6 | CID000005701 | |
| Drug | 2brh | 2.14e-06 | 21 | 102 | 4 | CID000848641 | |
| Drug | AC1L25Y6 | 3.15e-06 | 23 | 102 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 3.15e-06 | 23 | 102 | 4 | CID000165791 | |
| Drug | nimodipine | 4.10e-06 | 145 | 102 | 7 | CID000004497 | |
| Drug | Bay K 8644 | 5.12e-06 | 150 | 102 | 7 | CID000002303 | |
| Drug | dodecyl ether | 5.26e-06 | 26 | 102 | 4 | CID000020667 | |
| Drug | indo-1 | 5.58e-06 | 99 | 102 | 6 | CID000105060 | |
| Drug | AC1L1JAO | 5.69e-06 | 57 | 102 | 5 | CID000004955 | |
| Drug | CaCl2 | 6.63e-06 | 156 | 102 | 7 | CID000024854 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 1.02e-05 | 233 | 102 | 8 | CID000005114 | |
| Drug | strontium | 1.36e-05 | 68 | 102 | 5 | CID000104798 | |
| Drug | TMB-8 | 1.46e-05 | 176 | 102 | 7 | CID000005494 | |
| Drug | fluorescamine | 1.79e-05 | 35 | 102 | 4 | CID000037927 | |
| Drug | fluo-3 | 1.85e-05 | 122 | 102 | 6 | CID000104978 | |
| Drug | caloxin 1b1 | 1.99e-05 | 2 | 102 | 2 | ctd:C510327 | |
| Drug | phosphocreatine disodium | 2.22e-05 | 126 | 102 | 6 | CID000000587 | |
| Drug | dihydropyridine | 2.64e-05 | 193 | 102 | 7 | CID000104822 | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 3705_DN | |
| Drug | carbidine | 3.07e-05 | 40 | 102 | 4 | CID000065684 | |
| Drug | Carteolol hydrochloride [51781-21-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 3276_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 1694_UP | |
| Drug | C070379 | 3.21e-05 | 199 | 102 | 7 | CID003034747 | |
| Drug | isoflurane | 3.73e-05 | 279 | 102 | 8 | CID000003763 | |
| Drug | linopirdine | 4.10e-05 | 43 | 102 | 4 | CID000003932 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1E CASR BCR ITPR1 HGS PLCL2 PKD1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.85e-05 | 568 | 102 | 11 | CID000000806 |
| Drug | AC1MMLID | 5.90e-05 | 92 | 102 | 5 | CID000013245 | |
| Drug | AC1L1G0K | 6.89e-05 | 49 | 102 | 4 | CID000003473 | |
| Drug | nitrous oxide | 7.23e-05 | 96 | 102 | 5 | CID000000948 | |
| Drug | acetyl phosphate | 7.98e-05 | 98 | 102 | 5 | CID000000186 | |
| Drug | dioxotechnetium-99 | 8.03e-05 | 19 | 102 | 3 | CID000450469 | |
| Drug | calmidazolium chloride | 8.46e-05 | 160 | 102 | 6 | CID000002531 | |
| Drug | halothane | 8.54e-05 | 314 | 102 | 8 | CID000003562 | |
| Drug | 1,4-dibromobutane | 9.39e-05 | 53 | 102 | 4 | CID000008056 | |
| Drug | AC1NSKPI | 1.25e-04 | 57 | 102 | 4 | CID005311482 | |
| Drug | aqua regia | 1.26e-04 | 22 | 102 | 3 | CID000062687 | |
| Drug | AC1L1KS5 | 1.31e-04 | 334 | 102 | 8 | CID000005631 | |
| Drug | toxaphene | 1.34e-04 | 58 | 102 | 4 | CID005284469 | |
| Drug | ethylketocyclazocine | 1.34e-04 | 58 | 102 | 4 | CID000135018 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.47e-04 | 177 | 102 | 6 | 4652_DN | |
| Drug | sanguinarine | 1.53e-04 | 60 | 102 | 4 | CID000005154 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.29e-04 | 192 | 102 | 6 | 4180_UP | |
| Drug | chlordecone | 2.34e-04 | 67 | 102 | 4 | CID000000299 | |
| Drug | splitomicin; Up 200; 20uM; PC3; HG-U133A | 2.42e-04 | 194 | 102 | 6 | 661_UP | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.42e-04 | 194 | 102 | 6 | 4309_DN | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HG-U133A | 2.49e-04 | 195 | 102 | 6 | 325_UP | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 2.51e-04 | 125 | 102 | 5 | CID000002603 | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 1691_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 102 | 6 | 6715_UP | |
| Drug | bepridil | 2.60e-04 | 126 | 102 | 5 | CID000002351 | |
| Drug | tBuBHQ | 2.62e-04 | 69 | 102 | 4 | CID000002374 | |
| Drug | L-beta-aspartyl phosphate | 2.62e-04 | 69 | 102 | 4 | CID000000832 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 3577_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; ssMCF7; HG-U133A | 2.63e-04 | 197 | 102 | 6 | 415_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 4976_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 4078_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 2.63e-04 | 197 | 102 | 6 | 3303_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 2.70e-04 | 198 | 102 | 6 | 5837_UP | |
| Drug | caged ATP | 2.77e-04 | 70 | 102 | 4 | CID000123806 | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 3287_UP | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 7250_DN | |
| Drug | gadolinium | 2.78e-04 | 199 | 102 | 6 | CID000023982 | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.78e-04 | 199 | 102 | 6 | 4400_UP | |
| Drug | azathioprine, USP; Down 200; 100uM; MCF7; HG-U133A | 2.85e-04 | 200 | 102 | 6 | 338_DN | |
| Drug | Pyrethroids | 2.93e-04 | 71 | 102 | 4 | CID000005053 | |
| Drug | monobromobimane | 3.09e-04 | 72 | 102 | 4 | CID000114810 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.78e-09 | 6 | 99 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Familial aplasia of the vermis | 5.54e-07 | 20 | 99 | 4 | cv:C0431399 | |
| Disease | Meckel syndrome (implicated_via_orthology) | 2.03e-06 | 8 | 99 | 3 | DOID:0050778 (implicated_via_orthology) | |
| Disease | obsolete aging, brain measurement | 1.11e-05 | 2 | 99 | 2 | EFO_0004464, GO_0007568 | |
| Disease | Meckel-Gruber syndrome | 1.62e-05 | 15 | 99 | 3 | C0265215 | |
| Disease | Meckel syndrome type 1 | 2.88e-05 | 18 | 99 | 3 | C3714506 | |
| Disease | COACH syndrome | 3.34e-05 | 3 | 99 | 2 | cv:C1857662 | |
| Disease | Hepatic Fibrosis, Congenital | 3.34e-05 | 3 | 99 | 2 | C0009714 | |
| Disease | interleukin-6 measurement | 3.88e-05 | 112 | 99 | 5 | EFO_0004810 | |
| Disease | red blood cell density measurement | STON1 DNAH2 ITGA1 VAC14 SALL1 RABEP1 PLCL2 CC2D2A ADGRF5 HSF2 ATP2B4 VPS13B | 3.94e-05 | 880 | 99 | 12 | EFO_0007978 |
| Disease | Polydactyly | 4.78e-05 | 117 | 99 | 5 | C0152427 | |
| Disease | COACH syndrome | 6.66e-05 | 4 | 99 | 2 | C1857662 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 1.23e-04 | 228 | 99 | 6 | EFO_0003948, MONDO_0004975 | |
| Disease | Familial aplasia of the vermis | 1.39e-04 | 30 | 99 | 3 | C0431399 | |
| Disease | myocardial infarction | 1.82e-04 | 350 | 99 | 7 | EFO_0000612 | |
| Disease | clopidogrel metabolite measurement | 1.86e-04 | 33 | 99 | 3 | EFO_0007966 | |
| Disease | Arima syndrome | 2.31e-04 | 7 | 99 | 2 | C1855675 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 3.08e-04 | 8 | 99 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | free cholesterol in medium LDL measurement | 3.31e-04 | 40 | 99 | 3 | EFO_0022268 | |
| Disease | cortical thickness | MON2 ABCA4 STON1 ME1 CLOCK ITIH5 SEMA3A AGBL4 TMEM106B PKD1 KCNK2 OSMR | 3.53e-04 | 1113 | 99 | 12 | EFO_0004840 |
| Disease | CCL17 measurement | 3.95e-04 | 9 | 99 | 2 | EFO_0009414 | |
| Disease | macula measurement | 4.49e-04 | 189 | 99 | 5 | EFO_0008375 | |
| Disease | Meckel-Gruber syndrome | 4.93e-04 | 10 | 99 | 2 | cv:C0265215 | |
| Disease | carbohydrate measurement | 5.01e-04 | 46 | 99 | 3 | EFO_0004998 | |
| Disease | Ciliopathies | 5.24e-04 | 110 | 99 | 4 | C4277690 | |
| Disease | pneumonia, COVID-19 | 5.80e-04 | 113 | 99 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | phospholipids in medium LDL measurement | 6.03e-04 | 49 | 99 | 3 | EFO_0022183 | |
| Disease | free cholesterol in LDL measurement | 6.40e-04 | 50 | 99 | 3 | EFO_0022266 | |
| Disease | free cholesterol in large LDL measurement | 6.79e-04 | 51 | 99 | 3 | EFO_0022176 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 6.83e-04 | 118 | 99 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | total lipids in LDL measurement | 7.19e-04 | 52 | 99 | 3 | EFO_0022308 | |
| Disease | C-C motif chemokine 17 measurement | 7.20e-04 | 12 | 99 | 2 | EFO_0008045 | |
| Disease | intracranial aneurysm (is_implicated_in) | 7.20e-04 | 12 | 99 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Disorder of eye | 7.56e-04 | 212 | 99 | 5 | C0015397 | |
| Disease | phospholipids in large LDL measurement | 7.60e-04 | 53 | 99 | 3 | EFO_0022174 | |
| Disease | free cholesterol in small LDL measurement | 7.60e-04 | 53 | 99 | 3 | EFO_0022271 | |
| Disease | total lipids in large LDL | 9.40e-04 | 57 | 99 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 9.40e-04 | 57 | 99 | 3 | EFO_0021901 | |
| Disease | multiple myeloma, monoclonal gammopathy | 9.88e-04 | 14 | 99 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 9.88e-04 | 14 | 99 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | phospholipids in LDL measurement | 9.89e-04 | 58 | 99 | 3 | EFO_0022294 | |
| Disease | phospholipids in small LDL measurement | 1.04e-03 | 59 | 99 | 3 | EFO_0022297 | |
| Disease | calcium measurement | 1.26e-03 | 628 | 99 | 8 | EFO_0004838 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.30e-03 | 16 | 99 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 1.47e-03 | 17 | 99 | 2 | OBA_2045173 | |
| Disease | Age-related macular degeneration | 1.65e-03 | 18 | 99 | 2 | cv:C0242383 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.65e-03 | 18 | 99 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.00e-03 | 74 | 99 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Joubert syndrome 1 | 2.24e-03 | 21 | 99 | 2 | C4551568 | |
| Disease | sphingomyelin measurement | 2.49e-03 | 278 | 99 | 5 | EFO_0010118 | |
| Disease | generalized anxiety disorder | 2.69e-03 | 23 | 99 | 2 | EFO_1001892 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.78e-03 | 713 | 99 | 8 | EFO_0005689 | |
| Disease | vital capacity | DIS3L2 STON1 ATAD5 GRK5 TRIM24 ITPR1 SEMA3A TXNL1 HMCN1 HGS KCNK2 | 2.89e-03 | 1236 | 99 | 11 | EFO_0004312 |
| Disease | intermediate density lipoprotein measurement | 3.17e-03 | 87 | 99 | 3 | EFO_0008595 | |
| Disease | systemic mastocytosis | 3.18e-03 | 25 | 99 | 2 | MONDO_0016586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEISQQVRFKTVTVL | 311 | Q96QE3 | |
| SFQQVVKLKGQVLSV | 411 | P27540 | |
| VNALKTVSTFEVQIV | 386 | Q5NDL2 | |
| IAQLSQQSLDFVKII | 401 | Q15758 | |
| QQSLDFVKIITILVT | 406 | Q15758 | |
| CVVTSLKNVFNILIV | 1281 | Q15878 | |
| VTQTTLDQVFVNFAK | 2236 | P78363 | |
| PVLTSQQIETIFFKV | 536 | P11274 | |
| QIQVKQNISVTLRTF | 506 | Q9H5V8 | |
| VEVIQNSTAKVIVVF | 256 | P41180 | |
| QQLSFLKEVSTVIVV | 1131 | Q7Z2Y8 | |
| IIFQGKTSKTIFQQI | 866 | Q9UK96 | |
| NFFIASVNTLVNKTI | 236 | P53367 | |
| LKVTTFAQLIIQVAS | 61 | Q9BYV8 | |
| IVNVQSVDEAIKFIN | 261 | P48448 | |
| QQVITIFSLVEVVLQ | 831 | Q8IYB7 | |
| IKVLQFLVDQFLTTN | 361 | Q12830 | |
| NKVFTAVNILVLLFV | 191 | P52569 | |
| SISKFLQFQLTVNVV | 851 | P20020 | |
| LQFQLTVNVVAVIVA | 856 | P20020 | |
| SKFLQFQLTVNVVAV | 876 | Q01814 | |
| KFLQFQLTVNVVAVI | 851 | Q16720 | |
| SKFLQFQLTVNVVAV | 841 | P23634 | |
| VLFVSQIQIESIFNI | 236 | Q8N123 | |
| VFQIQISRIETSNVI | 66 | Q99650 | |
| QVQRDFVKLSQTLQV | 816 | Q15276 | |
| TTILTQVFIKVIDTN | 1436 | Q14517 | |
| AFATVLTQNQAIKAI | 226 | Q8IZ02 | |
| NIFLTTAEVIAQQVS | 476 | P48163 | |
| KVNIVTQEIFKTNFV | 3116 | Q5T1H1 | |
| QINSFQVFVEEVLKI | 216 | Q4G0X4 | |
| TVINQNETFANIIFK | 226 | Q86UX2 | |
| TALQVFIQVNVLVSF | 201 | O95665 | |
| QEVLQAFKQVQLLVT | 1101 | Q14643 | |
| NESVVSIAAQQKFVL | 431 | Q13201 | |
| ETLVVFAINLKQLNV | 4401 | Q2LD37 | |
| QRTTIVIQKQTFISQ | 91 | O95069 | |
| VEFLSTSIAQLKVVQ | 26 | Q99471 | |
| QALTEFNTAIQEIVV | 61 | Q53H82 | |
| IKTKQIQEQVVQFLF | 296 | Q8NGK2 | |
| FQRVAISTFQKAIQE | 371 | Q96MW5 | |
| GLFKQSIEINVITAQ | 141 | Q8IV20 | |
| RQQVTEIIFVLKAVS | 1636 | Q7Z3U7 | |
| IVRSQNDKFNVSLTV | 831 | P56199 | |
| LDIFISSVQKVFQVV | 316 | Q9Y251 | |
| VLQLIQQKQSQVVFV | 156 | Q96RW7 | |
| FFKLVLVNEVSQQVE | 266 | Q5T8I9 | |
| VVNDTIAFVKNIITT | 406 | P42357 | |
| KSLLVNNIFVVSAAI | 96 | Q9BYW1 | |
| TASLQSVKDVVFINI | 1141 | Q9P2K1 | |
| IKVFVLTSNFQAIRV | 211 | Q9H2C2 | |
| TLFVVDVQTSQITKI | 111 | Q5T6F0 | |
| VQNIFTAAKLVIVAI | 176 | P82251 | |
| VISNLETKQVQGISF | 1681 | O75417 | |
| TVENVKESQRVIFNI | 86 | Q5VU57 | |
| FQKLNTSIQVVLLSA | 201 | Q14240 | |
| KIEVLVSNATQFIIL | 96 | Q6P179 | |
| FLVVKTLQAQLQVTN | 66 | O60676 | |
| QILEKVNSQFVVNLA | 236 | P34947 | |
| VQKEETVTNIQFVLL | 1001 | Q9P225 | |
| LQEQKTVLASVFSVL | 316 | Q96ER3 | |
| IIENLQSTKVAVAQF | 196 | Q9NSC2 | |
| VTTNRQTITLTKFIQ | 111 | A3KN83 | |
| NTKIIKNFTLEQIVT | 776 | Q68D06 | |
| VLVFADSQVNQKSTV | 456 | Q8TDX9 | |
| QVTVTAVAITFDKNQ | 786 | Q86YS7 | |
| DKQSLTFQNVVFNVI | 971 | P98161 | |
| SIITNQFVAKASVFI | 141 | Q8NGH5 | |
| SVVIVNLFVNESVTN | 796 | Q9BZA8 | |
| LKILQEVTAGQTVFN | 196 | Q99487 | |
| QQQVIRKIVQFIVTL | 171 | Q03933 | |
| FIVTLVQNNQLVSLK | 181 | Q03933 | |
| QTVRKINSLFQVLTV | 681 | Q5HYA8 | |
| EVENITAQVQFSKTV | 161 | Q9NUM4 | |
| KIFVVATRQAQQITT | 221 | O14804 | |
| SQFTEIFIKQQENVT | 111 | O60763 | |
| LVREFVAQNNTVQIK | 36 | Q08AM6 | |
| LFVVRQKEAVVSFQV | 81 | Q8NBJ9 | |
| IFNETEVIVFIKVVQ | 701 | Q4G0N8 | |
| VTQITVALSSLKNIF | 436 | Q8NDZ6 | |
| ETFVFAIKLQNLQTV | 291 | Q8N9U0 | |
| NLQTVRLVFKIQTQT | 301 | Q8N9U0 | |
| VKVVSQSFIRALNQT | 1256 | B5MCY1 | |
| TLNVTFKNEIQSFLV | 6 | Q14596 | |
| TSQIVFRSVIDIINK | 491 | Q9UPR0 | |
| IVLQSVFTSVRQKIE | 1551 | P51532 | |
| TLITENFKNVNFTTI | 226 | O15457 | |
| IVIKTDVNYQFTQIV | 421 | Q14563 | |
| ANIKVTFISVANLTI | 461 | Q8IZF2 | |
| IRFSQGQQLVTKLVT | 701 | O15516 | |
| ELKVETQFVNQFTTQ | 1246 | Q8N2E2 | |
| EAFQNQKVIIDTLIT | 261 | O15164 | |
| VNVQEFEQSRIIKFV | 491 | Q9Y6Q2 | |
| EQFLKALQNAVTTFV | 406 | O14964 | |
| QQKTVQFVLQFVVTL | 141 | Q9C0B7 | |
| IKTVKLAFSVTNNVI | 811 | Q5SRE5 | |
| KVNTVQFNEEATVIL | 111 | Q9BRX9 | |
| IFVKSLQSVQKVIIS | 301 | Q3SXZ7 | |
| RIKIFVFQNQVVTTI | 286 | Q9H6L2 | |
| FQKISVQTTQIVISM | 2131 | Q7Z7G8 | |
| VQKLFANIAEVTITI | 36 | Q9NX45 | |
| IQQKRTVAFLNQFVV | 21 | Q9Y3C0 | |
| AAQEVIKIITKQFVI | 501 | Q13564 | |
| IIVALFQGQFKSTVQ | 921 | P40818 | |
| TNVVQKICFSTQIIR | 121 | A6NCI4 | |
| VKFQNVNSVTIFVQS | 236 | O43396 | |
| QNTVVLFSNTDKFVL | 1361 | O14686 |